Hannah Tuson
About Hannah Tuson
Hannah Tuson is the Director of Discovery at Locus Biosciences, Inc., where she has worked since 2021. She holds a Ph.D. in Biochemistry from the University of Wisconsin-Madison and has extensive experience in microbiome and bacteriophage therapy.
Current Role as Director of Discovery
Hannah Tuson currently serves as the Director of Discovery at Locus Biosciences, Inc., a position she has held since 2021. In this role, she oversees various discovery projects, focusing on advancements in microbiome and bacteriophage therapy. Her leadership contributes to the strategic direction of research initiatives within the company, which is located in Morrisville, North Carolina.
Previous Experience at Locus Biosciences
Prior to her current role, Tuson held multiple positions at Locus Biosciences, Inc. She worked as a Senior Scientist from 2018 to 2020 and then transitioned to the role of Associate Director of Discovery from 2020 to 2021. Her tenure at the company has spanned several years, during which she has contributed to the development of innovative therapies in the field of microbiome research.
Educational Background in Biochemistry
Hannah Tuson earned her Ph.D. in Biochemistry from the University of Wisconsin-Madison, where she studied from 2006 to 2012. Her academic journey also includes a Bachelor of Science degree in Biochemistry from Lafayette College, completed in 2006. Additionally, she participated in a Physiology Course at the Marine Biological Laboratory in 2009, further enhancing her expertise in the biological sciences.
Postdoctoral Research Experience
Tuson completed her postdoctoral research at the University of Michigan from 2013 to 2017. This four-year experience allowed her to deepen her research skills and knowledge in biochemistry and related fields. Her work during this period contributed to her development as a scientist and prepared her for subsequent roles in the biotechnology sector.
Research and Development Focus
Hannah Tuson is actively involved in research and development projects that focus on microbiome and bacteriophage therapy. Her work aims to explore innovative solutions within these fields, contributing to advancements in therapeutic options and understanding of microbial interactions. This focus aligns with current trends in biotechnology and personalized medicine.